PE-22-28 is a synthetic heptapeptide derived from the natural peptide spadin. Both target the TREK-1 potassium channel, but preclinical evidence shows PE-2
Read more PE-22-28 vs. Spadin: Comparative Evidence in TREK-1 Potassium Channel Research
PE-22-28 is a synthetic heptapeptide derived from spadin that selectively inhibits TREK-1 potassium channels. In rodent models, it accelerates hippocampal
Read more PE-22-28 and Neuroplasticity: Preclinical Evidence, Mechanisms, and Limitations
PE-22-28 is a synthetic, shortened derivative of spadin that selectively inhibits TREK-1 potassium channels, showing rapid-onset neurogenic and antidepress
Read more PE-22-28 Research Peptide: Mechanism, TREK-1 Blockade, and Preclinical Evidence